Great West Life Assurance CO Apellis Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 18,736 shares of APLS stock, worth $705,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,736
Previous 16,677
12.35%
Holding current value
$705,035
Previous $981,000
26.71%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$617 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$437 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$418 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$369 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$218 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.13B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...